Skip to main content

Nicotine

NDC 51316-787 · CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED

Generic namenicotine polacrilex
Dosage formLOZENGE
RouteORAL
Active ingredient(s)NICOTINE
Strength4 mg/1
Pharmacologic classCholinergic Nicotinic Agonist [EPC], Nicotine [CS]
Marketing categoryANDA

Packages

51316-787-60 — 1 CONTAINER in 1 CARTON (51316-787-60) / 20 LOZENGE in 1 CONTAINER

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-7061 — Nicotine Polacrilex, 50090-7063 — nicotine polacrilex, 50090-7936 — Nicotine, 50742-668 — Nicotine Transdermal System, 50742-669 — Nicotine Transdermal System, 50742-670 — Nicotine Transdermal System, 51316-151 — Nicotine polacrilex, 51316-190 — Nicotine Polacrilex, 51316-309 — Nicotine Polacrilex, 51316-319 — nicotine polacrilex, 53329-191 — nicotine, 53329-192 — nicotine, 53329-193 — nicotine, 55301-428 — Nicotine Polacrilex, 55301-429 — Nicotine Polacrilex, 55301-503 — Nicotine Polacrilex, 55301-504 — Nicotine Polacrilex, 55301-617 — Nicotine Polacrilex, 55301-734 — Nicotine Polacrilex, 55301-873 — Nicotine Polacrilex, +734 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels